The Impact of Hypoxia on the Biochemical and Morphological Parameters of Blood in Rowers.
IHOBMPBR
The Effects of Live High-train Low on EPO, VEGF, and Hematological Variables in Elite Rowers
1 other identifier
interventional
14
0 countries
N/A
Brief Summary
The response to hypoxia is very individual and depending on many aspects, such as the type of training, duration, intensity, or hypoxic stimulus, hypoxia affects the athlete in various ways. This multi-stage study investigated hematological and physiological responses to normobaric Live High-Train Low (LHTL) exposure in elite male rowers from the Polish national rowing team. Stage I evaluated responses during an 18-day LHTL intervention, whereas Stage II evaluated responses during a 14-day LHTL intervention and extended the assessment to 42 days after return to normoxia. The study focused particularly on hematological variables, erythropoietin (EPO), vascular endothelial growth factor (VEGF), and other physiological and biochemical responses associated with hypoxic exposure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2015
CompletedFirst Submitted
Initial submission to the registry
January 10, 2024
CompletedFirst Posted
Study publicly available on registry
February 16, 2024
CompletedSeptember 21, 2026
September 1, 2026
1.1 years
January 10, 2024
September 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Erythropoietin (EPO) mlU/ml
immunoenzymatic assay methods using diagnostic kits
Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.
Vascular endothelial growth factor (VEGF) mlU/ml
immunoenzymatic assay methods using diagnostic kits
Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.
Secondary Outcomes (9)
Creatine kinase (CK) ng/ml
Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.
Hs C-Reactive Protein (hsCRP) mg/L
Stage 1: at baseline and on days 6, 12, and 18 of the intervention.
Hemoglobin (Hb)g/dL
Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.
Hematocrit (Htc)%
Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.
Red blood cells (RBC)mln/mm3
Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.
- +4 more secondary outcomes
Other Outcomes (5)
Body mass (kg)
Stage 1: baseline and Days 6, 12, and 18 of the intervention; Stage 2: baseline and Days 7 and 14 of the intervention, and 8, 14, and 42 days after the intervention.
Body fat percentage (%)
Stage 1: baseline and Days 6, 12, and 18 of the intervention; Stage 2: baseline and Days 7 and 14 of the intervention, and 8, 14, and 42 days after the intervention.
Fat mass (kg)
Stage 1: baseline and Days 6, 12, and 18 of the intervention; Stage 2: baseline and Days 7 and 14 of the intervention, and 8, 14, and 42 days after the intervention.
- +2 more other outcomes
Study Arms (2)
LHTL
EXPERIMENTALParticipants assigned to the LHTL group underwent their regular sports training while living in normobaric hypoxic rooms.
Control group
NO INTERVENTIONParticipants assigned to the control group completed the same sports training as the LHTL group while living in normoxic conditions at the same training camp.
Interventions
Participants lived in normobaric hypoxic rooms for 14-16 h per day while completing their regular training under normoxic conditions. The simulated altitude was progressively increased during the intervention.
Eligibility Criteria
You may qualify if:
- Male national-team rowers aged ≥18 years.
- Regular participation in rowing training.
- Participation in the training camp.
You may not qualify if:
- Exposure to hypoxic conditions or altitude above 1500 m within 1 month before the study.
- Medical contraindications or adverse symptoms associated with hypoxic exposure.
- Injury or health condition preventing participation in the training program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (5)
Kasperska A, Zembron-Lacny A. The effect of intermittent hypoxic exposure on erythropoietic response and hematological variables in elite athletes. Physiol Res. 2020 Apr 30;69(2):283-290. doi: 10.33549/physiolres.934316. Epub 2020 Mar 23.
PMID: 32199016BACKGROUNDWilber RL. Application of altitude/hypoxic training by elite athletes. Med Sci Sports Exerc. 2007 Sep;39(9):1610-24. doi: 10.1249/mss.0b013e3180de49e6.
PMID: 17805095BACKGROUNDCzuba M, Fidos-Czuba O, Ploszczyca K, Zajac A, Langfort J. Comparison of the effect of intermittent hypoxic training vs. the live high, train low strategy on aerobic capacity and sports performance in cyclists in normoxia. Biol Sport. 2018 Mar;35(1):39-48. doi: 10.5114/biolsport.2018.70750. Epub 2017 Oct 11.
PMID: 30237660RESULTPloszczyca K, Langfort J, Czuba M. The Effects of Altitude Training on Erythropoietic Response and Hematological Variables in Adult Athletes: A Narrative Review. Front Physiol. 2018 Apr 11;9:375. doi: 10.3389/fphys.2018.00375. eCollection 2018.
PMID: 29695978RESULTKasperska A, Dziewiecka H, Jankowski W, Mikulski T, Czerniec I, Skarpanska-Stejnborn A, Ostapiuk-Karolczuk J. Hematological, inflammatory, and hypoxia-responsive adaptations to 18-day normobaric live high-train low training in elite rowers. Front Physiol. 2026 May 13;17:1834329. doi: 10.3389/fphys.2026.1834329. eCollection 2026.
PMID: 42222289DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Kasperska
Poznań University of Physical Education, Faculty of Sport Sciences in Gorzów Wielkopolski, Poland;
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Participants were randomly assigned to one of two parallel groups: a hypoxic Live High-Train Low (LHTL) group, which underwent the same sports training while living in normobaric hypoxic conditions, and a control (CON) group, which completed the same training while living in normoxic conditions.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2024
First Posted
February 16, 2024
Study Start
November 30, 2014
Primary Completion
December 21, 2015
Study Completion
December 21, 2015
Last Updated
September 21, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to participant confidentiality and data protection considerations.